Clinical Approach to Sleep Disturbance
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of sleep disturbance
Sleep disturbance is one of the most prevalent complaints in primary care, affecting approximately 30 to 35% of adults at some point in their lives, with 10 to 15% experiencing chronic insomnia. It accounts for an estimated 5.5 million physician visits annually in the United States alone. The economic burden is substantial, with insomnia-related costs exceeding $100 billion annually when accounting for direct healthcare expenses, lost productivity, and accident-related costs. Beyond statistics, sleep disturbance profoundly impacts quality of life, cognitive function, mood regulation, cardiovascular health, and immune function.
Definition
Sleep disturbance encompasses a broad spectrum of conditions characterized by dissatisfaction with sleep quality, timing, or duration, resulting in daytime impairment. This includes difficulty initiating sleep (sleep-onset insomnia), difficulty maintaining sleep (sleep-maintenance insomnia), early morning awakening, non-restorative sleep, and disorders of excessive daytime sleepiness. True insomnia disorder requires symptoms occurring at least three nights per week for at least three months, with adequate opportunity for sleep and associated daytime dysfunction.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute (Adjustment) Insomnia | Less than 2 weeks | Acute stress, jet lag, environmental change, acute illness, bereavement | Usually self-limiting; reassurance and sleep hygiene often sufficient; avoid hypnotics if possible |
| Short-term Insomnia | 2 weeks to 3 months | Persistent stressors, developing psychiatric conditions, medication effects, subacute medical illness | Risk of chronification; early intervention important; address underlying causes; consider brief cognitive behavioral therapy |
| Chronic Insomnia | Greater than 3 months | Chronic insomnia disorder, psychiatric comorbidity, chronic pain, obstructive sleep apnea, restless legs syndrome | Requires systematic evaluation; cognitive behavioral therapy for insomnia is first-line treatment; often multifactorial |
Classification by Character
Sleep-Onset Insomnia
Definition: Difficulty falling asleep, typically defined as sleep latency greater than 30 minutes.
Suggests: Anxiety disorders, circadian rhythm disorders (delayed sleep phase), restless legs syndrome, poor sleep hygiene, stimulant use, conditioned arousal.
Sleep-Maintenance Insomnia
Definition: Frequent awakenings or prolonged wakefulness after sleep onset, with total wake time after sleep onset exceeding 30 minutes.
Suggests: Obstructive sleep apnea, depression, chronic pain, nocturia, periodic limb movement disorder, alcohol use, medication effects.
Early Morning Awakening
Definition: Waking earlier than desired (typically more than 30 minutes before intended wake time) with inability to return to sleep.
Suggests: Major depressive disorder (classic feature), advanced sleep phase syndrome (common in elderly), anxiety, alcohol withdrawal.
Non-Restorative Sleep
Definition: Sleep of adequate duration but poor quality, leaving the patient feeling unrefreshed upon waking.
Suggests: Obstructive sleep apnea, fibromyalgia, chronic fatigue syndrome, alpha-delta sleep anomaly, medication effects, periodic limb movements.
Disorders of Excessive Daytime Sleepiness
| Pattern | Description | Key Differential Diagnoses |
|---|---|---|
| Excessive daytime sleepiness with snoring | Uncontrollable sleepiness despite adequate sleep opportunity, witnessed apneas, loud snoring | Obstructive sleep apnea (most common) |
| Excessive sleepiness with cataplexy | Sudden muscle weakness triggered by strong emotions, sleep paralysis, hypnagogic hallucinations | Narcolepsy type 1 |
| Excessive sleepiness without cataplexy | Chronic sleepiness without associated features, often onset in adolescence | Narcolepsy type 2, idiopathic hypersomnia, insufficient sleep syndrome |
| Recurrent hypersomnia | Episodic excessive sleep lasting days to weeks with normal intervals | Kleine-Levin syndrome (rare) |
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Difficulty falling asleep at conventional bedtime but sleeping well once asleep | Sleep-onset delayed until 2 to 6 AM, difficulty waking for work or school | Delayed sleep-wake phase disorder (common in adolescents and young adults) |
| Early evening sleepiness with early morning awakening | Falling asleep at 7 to 9 PM, waking at 3 to 5 AM | Advanced sleep-wake phase disorder (common in elderly) |
| Irregular sleep-wake pattern | No consistent sleep schedule, multiple sleep episodes throughout 24 hours | Irregular sleep-wake rhythm disorder (associated with dementia, developmental disorders) |
| Sleep disturbance only on work nights | Good sleep on weekends and holidays, poor sleep before work days | Psychophysiological insomnia (conditioned arousal), work-related anxiety |
| Rotating or shift-related pattern | Insomnia or excessive sleepiness associated with work schedule | Shift work sleep disorder |
| Seasonal pattern | Sleep disturbance worse in winter months, associated with mood changes | Seasonal affective disorder |
Impact on Health and Function
Consequences of Untreated Sleep Disturbance
- Cardiovascular: Hypertension, coronary artery disease, heart failure, stroke, atrial fibrillation
- Metabolic: Obesity, type 2 diabetes mellitus, metabolic syndrome
- Psychiatric: Depression, anxiety, substance abuse, suicidal ideation
- Cognitive: Impaired memory, reduced concentration, decreased executive function
- Safety: Motor vehicle accidents (6-fold increase), occupational injuries
- Immunologic: Increased infection susceptibility, impaired vaccine response
Key Concept: The 3P Model of Insomnia
Understanding chronic insomnia requires the “3P” model:
- Predisposing factors: Genetic vulnerability, hyperarousal trait, female sex, older age, family history
- Precipitating factors: Acute stressors, illness, environmental changes that trigger initial insomnia
- Perpetuating factors: Maladaptive behaviors (excessive time in bed, irregular schedule, daytime napping) and cognitive distortions (worry about sleep, unrealistic expectations) that maintain insomnia after precipitants resolve
Treatment success depends on addressing perpetuating factors, which is why cognitive behavioral therapy for insomnia is more effective long-term than pharmacotherapy alone.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of sleep disturbance
Sleep is an active, highly regulated process governed by two primary systems: the homeostatic sleep drive (Process S) and the circadian rhythm (Process C). Understanding these mechanisms is essential for diagnosing sleep disorders and selecting appropriate treatments. Disruption of either system—or the balance between them—can result in sleep disturbance.
The Two-Process Model of Sleep Regulation
| Component | Mechanism | Key Features | Clinical Relevance |
|---|---|---|---|
| Process S (Homeostatic Sleep Drive) | Accumulation of adenosine and other sleep-promoting substances during wakefulness | Increases linearly during waking; dissipates during sleep; stronger with prolonged wakefulness | Explains why sleep restriction leads to increased sleepiness; caffeine blocks adenosine receptors; daytime naps reduce sleep drive |
| Process C (Circadian Rhythm) | Approximately 24-hour oscillation controlled by suprachiasmatic nucleus in hypothalamus | Entrained by light exposure; regulates timing of sleep propensity, alertness, hormone secretion, body temperature | Explains jet lag, shift work disorder, delayed and advanced sleep phase disorders; light therapy effectiveness |
Neural Circuitry of Sleep and Wakefulness
| System | Key Structures | Neurotransmitters | Function |
|---|---|---|---|
| Ascending Arousal System | Locus coeruleus, raphe nuclei, tuberomammillary nucleus, pedunculopontine and laterodorsal tegmental nuclei, basal forebrain | Norepinephrine, serotonin, histamine, acetylcholine, dopamine | Promotes and maintains wakefulness; active during day; inhibited during sleep |
| Orexin/Hypocretin System | Lateral hypothalamus | Orexin A and B (hypocretin 1 and 2) | Stabilizes wakefulness; prevents inappropriate transitions to sleep; loss causes narcolepsy type 1 |
| Sleep-Promoting System | Ventrolateral preoptic area (VLPO), median preoptic nucleus | GABA, galanin | Inhibits arousal centers to promote sleep; active during NREM sleep |
| Circadian Pacemaker | Suprachiasmatic nucleus (SCN) | Various neuropeptides including vasoactive intestinal peptide | Master clock; receives light input via retinohypothalamic tract; regulates melatonin secretion from pineal gland |
| REM Sleep Generator | Sublaterodorsal nucleus, pedunculopontine tegmentum | Acetylcholine (REM-on), norepinephrine and serotonin (REM-off) | Controls REM sleep; generates muscle atonia; dysfunction leads to REM sleep behavior disorder |
Key Neurotransmitters and Their Roles
Wake-Promoting
Norepinephrine: Alertness, attention; from locus coeruleus
Histamine: Arousal maintenance; antihistamines cause sedation
Orexin: Stabilizes wakefulness; target of dual orexin receptor antagonists
Dopamine: Reward, motivation, alertness; stimulants increase dopamine
Sleep-Promoting
GABA: Primary inhibitory neurotransmitter; benzodiazepines enhance GABA activity
Adenosine: Accumulates during wakefulness; caffeine is an adenosine antagonist
Melatonin: Circadian signal for sleep timing; secreted by pineal gland in darkness
Galanin: Co-released with GABA from VLPO neurons
Modulatory
Serotonin: Complex role; promotes wakefulness but involved in NREM sleep initiation
Acetylcholine: High during wake and REM; low during NREM sleep
Glutamate: Excitatory; involved in cortical arousal
Cortisol: Circadian rhythm; peaks in morning; elevated levels impair sleep
Normal Sleep Architecture
| Sleep Stage | Percentage of Total Sleep | Characteristics | Functions |
|---|---|---|---|
| N1 (Light Sleep) | 2 to 5% | Transition from wake; easily aroused; theta waves on EEG; slow eye movements | Sleep onset transition |
| N2 (Light Sleep) | 45 to 55% | Sleep spindles and K-complexes on EEG; reduced awareness of environment | Memory consolidation; sensory gating |
| N3 (Deep/Slow-Wave Sleep) | 15 to 25% | Delta waves (high amplitude, low frequency); difficult to arouse; predominates in first third of night | Physical restoration; growth hormone release; immune function; memory consolidation |
| REM Sleep | 20 to 25% | Rapid eye movements; muscle atonia; vivid dreams; EEG similar to wake; predominates in last third of night | Emotional processing; procedural and emotional memory consolidation; brain development |
Sleep Cycle Pattern: Normal adult sleep consists of 4 to 6 cycles of approximately 90 minutes each. The first cycles have more N3 (slow-wave) sleep, while later cycles have longer REM periods. Understanding this architecture helps explain why alcohol (which suppresses REM early in the night) causes early morning awakening when REM rebound occurs.
How Conditions Cause Sleep Disturbance
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Chronic Insomnia Disorder | Hyperarousal of central nervous system; increased cortisol and metabolic rate; conditioned arousal to bed environment; cognitive hypervigilance about sleep | Cognitive behavioral therapy for insomnia addresses perpetuating cognitive and behavioral factors; targets hyperarousal |
| Obstructive Sleep Apnea | Upper airway collapse during sleep causes hypoxia and hypercapnia, triggering arousal; fragmented sleep; reduced slow-wave and REM sleep | Continuous positive airway pressure maintains airway patency; weight loss reduces airway collapsibility |
| Restless Legs Syndrome | Dopaminergic dysfunction in central nervous system; low brain iron; urge to move legs disrupts sleep onset | Dopamine agonists; alpha-2-delta ligands; iron supplementation if ferritin is low |
| Circadian Rhythm Disorders | Misalignment between internal circadian clock and desired sleep-wake schedule; may involve genetic clock gene variants | Timed light exposure and melatonin to shift circadian phase; chronotherapy |
| Major Depressive Disorder | Altered neurotransmitter function (serotonin, norepinephrine); reduced REM latency; early morning awakening; reduced slow-wave sleep | Antidepressants may improve or worsen sleep depending on agent; sleep deprivation has paradoxical antidepressant effect |
| Generalized Anxiety Disorder | Heightened autonomic arousal; rumination and worry at bedtime; hypervigilance prevents transition to sleep | Cognitive behavioral therapy; anxiolytics; addressing worry and relaxation techniques |
| Narcolepsy Type 1 | Autoimmune destruction of orexin-producing neurons in hypothalamus; inability to maintain stable wakefulness or sleep | Wake-promoting agents (modafinil, stimulants); sodium oxybate for cataplexy and sleep consolidation |
| REM Sleep Behavior Disorder | Loss of normal REM atonia due to brainstem pathology; dream enactment; often precedes synucleinopathies | Bedroom safety; melatonin; clonazepam; screen for neurodegenerative disease |
Effects of Substances on Sleep Architecture
| Substance | Acute Effect | Chronic Effect / Withdrawal | Clinical Note |
|---|---|---|---|
| Alcohol | Decreases sleep latency; suppresses REM in first half of night | REM rebound causing vivid dreams and early awakening; tolerance develops; withdrawal causes severe insomnia | Often used as self-medication; worsens overall sleep quality despite initial sedation |
| Caffeine | Blocks adenosine receptors; increases sleep latency; reduces total sleep time | Withdrawal causes hypersomnia, headache; half-life 5 to 6 hours (longer in some individuals) | Avoid after noon for sensitive individuals; consider hidden sources |
| Cannabis | May decrease sleep latency; suppresses REM sleep | Withdrawal causes insomnia, vivid dreams; tolerance develops to sleep effects | Increasingly common; long-term effects poorly understood |
| Benzodiazepines | Decrease sleep latency; increase N2; decrease N3 and REM | Tolerance; dependence; rebound insomnia on discontinuation | Short-term use only; taper slowly to avoid withdrawal |
| Opioids | Sedation; suppress REM and N3; may cause central sleep apnea | Withdrawal causes severe insomnia; chronic use fragments sleep | Assess for sleep-disordered breathing in patients on chronic opioids |
Often Overlooked Mechanism: Hyperarousal in Insomnia
Patients with chronic insomnia demonstrate objective evidence of central nervous system hyperarousal: elevated 24-hour metabolic rate, increased high-frequency EEG activity during sleep, elevated cortisol levels, and increased sympathetic tone. This is not simply a failure to initiate sleep but rather an inability to reduce arousal. This explains why simply “trying harder” to sleep is counterproductive and why cognitive behavioral therapy for insomnia—which reduces cognitive and physiological arousal—is more effective than sedative medications for long-term management.
Age-Related Changes in Sleep
Normal Aging vs. Pathological Sleep Disturbance
Understanding normal age-related sleep changes prevents over-diagnosis:
- Decreased total sleep time: Older adults typically sleep 6 to 7 hours (vs. 7 to 9 in younger adults)
- Reduced slow-wave sleep: N3 sleep decreases significantly with age
- Advanced circadian phase: Earlier bedtime and wake time is normal
- Increased sleep fragmentation: More frequent brief awakenings
- Increased sleep latency: Slightly longer time to fall asleep
Key Point: These changes do not necessarily indicate pathology unless associated with significant daytime impairment. Older adults often have unrealistic expectations based on their sleep patterns from younger years.
3. History Taking
A comprehensive approach to eliciting the sleep disturbance history
Red Flags — Require Urgent Evaluation
- Witnessed apneas with excessive daytime sleepiness — Obstructive sleep apnea with cardiovascular risk
- Sudden-onset cataplexy — Narcolepsy type 1; rarely secondary to hypothalamic lesion
- Dream enactment behavior with injury — REM sleep behavior disorder; high risk of synucleinopathy
- New-onset insomnia with weight loss — Occult malignancy, hyperthyroidism, depression
- Severe sleepiness causing accidents or near-misses — Immediate driving restriction; urgent workup
- Insomnia with suicidal ideation — Psychiatric emergency; insomnia is independent risk factor for suicide
- New neurological symptoms with sleep changes — Consider structural lesion, neurodegenerative disease
- Unexplained hypersomnia in young person — Narcolepsy, idiopathic hypersomnia, brain tumor
Systematic History: The “SLEEPS” Approach
Use the mnemonic “SLEEPS” to ensure comprehensive sleep history taking:
- S — Sleep pattern and schedule: What time do you go to bed? What time do you wake up? How long does it take to fall asleep? How many times do you wake at night? Is this pattern different on weekends?
- L — Legs and movements: Do you have uncomfortable sensations in your legs at night? Does your bed partner report that you kick or move excessively? Do you act out dreams?
- E — Environment and habits: What is your bedroom like (temperature, light, noise, electronics)? What do you do in the hour before bed? Do you use screens in bed?
- E — Effects on daytime function: How does your sleep affect your daytime? Do you feel refreshed upon waking? Any accidents or near-misses from sleepiness? Impact on work, mood, relationships?
- P — Partners and witnesses: Does your bed partner notice snoring, pauses in breathing, or unusual movements? Have you been told you stop breathing?
- S — Substances and medications: Caffeine intake (including timing)? Alcohol use? Recreational drugs? Current medications? Prior sleep medication use?
Essential Assessment Tools
Sleep Diary and Validated Questionnaires
Sleep Diary: Gold standard for assessing sleep patterns. Patient records bedtime, wake time, sleep latency, number of awakenings, and daytime naps for 1 to 2 weeks. Essential before diagnosing insomnia or circadian rhythm disorders.
Key Validated Questionnaires:
- Epworth Sleepiness Scale: 8 questions; score greater than 10 suggests excessive daytime sleepiness; score greater than 15 is severe
- STOP-BANG Questionnaire: Screens for obstructive sleep apnea; score of 3 or more indicates high risk
- Insomnia Severity Index: 7 questions; score greater than 14 indicates clinical insomnia
- Pittsburgh Sleep Quality Index: Comprehensive sleep quality assessment; score greater than 5 indicates poor sleep quality
- International Restless Legs Syndrome Study Group Rating Scale: Assesses restless legs syndrome severity
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Obstructive Sleep Apnea | Snoring, witnessed apneas, gasping, nocturia, morning headaches, unrefreshing sleep | “Has anyone told you that you snore loudly or stop breathing during sleep? Do you wake up gasping or choking?” |
| Chronic Insomnia Disorder | Difficulty initiating or maintaining sleep despite adequate opportunity; daytime impairment; worry about sleep | “Do you lie in bed worrying about not being able to sleep? What goes through your mind when you can’t sleep?” |
| Restless Legs Syndrome | Urge to move legs with uncomfortable sensations; worse at rest and evening; relief with movement | “Do you get an uncomfortable urge to move your legs when you’re sitting or lying down, especially in the evening? Does moving help?” |
| Delayed Sleep-Wake Phase Disorder | Inability to fall asleep at conventional time; difficulty waking for obligations; normal sleep when allowed to follow preferred schedule | “If you could sleep whenever you wanted—like on vacation—what time would you naturally fall asleep and wake up?” |
| Depression | Early morning awakening, low mood, anhedonia, fatigue, appetite changes, concentration difficulty | “How has your mood been lately? Have you lost interest in activities you used to enjoy? Do you wake up very early and can’t get back to sleep?” |
| Generalized Anxiety Disorder | Difficulty falling asleep due to racing thoughts, worry, physical tension | “When you lie down to sleep, do you find your mind racing with worries? What kinds of thoughts keep you awake?” |
| Narcolepsy | Excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic hallucinations, disrupted nighttime sleep | “Do you ever feel sudden muscle weakness when you laugh or feel strong emotions? Have you ever been paralyzed when falling asleep or waking up?” |
| REM Sleep Behavior Disorder | Dream enactment, shouting during sleep, falling out of bed, injury to self or bed partner | “Have you ever acted out your dreams while asleep—such as punching, kicking, or falling out of bed? Has your bed partner been injured?” |
| Shift Work Sleep Disorder | Insomnia or sleepiness related to work schedule; symptoms improve on days off | “What are your work hours? Do you sleep better on your days off? How long have you worked this schedule?” |
| Periodic Limb Movement Disorder | Unrefreshing sleep, excessive daytime sleepiness; bed partner reports repetitive leg jerks | “Does your bed partner say your legs jerk repeatedly during the night? Do you kick off the covers or find the sheets in disarray?” |
Medical and Psychiatric History
| Comorbid Condition | Sleep Impact | Key Questions |
|---|---|---|
| Chronic Pain | Difficulty initiating and maintaining sleep; reduced slow-wave sleep; bidirectional relationship (poor sleep worsens pain) | “Does pain wake you up at night or prevent you from falling asleep? Where is the pain worst?” |
| Heart Failure | Paroxysmal nocturnal dyspnea, orthopnea, Cheyne-Stokes respiration, central sleep apnea | “Do you need to prop yourself up with pillows to sleep? Do you wake up suddenly short of breath?” |
| Gastroesophageal Reflux Disease | Awakening with heartburn, cough, or choking; may trigger or worsen asthma symptoms | “Do you wake up with heartburn, acid taste in your mouth, or coughing? Is it worse when you eat late?” |
| Chronic Obstructive Pulmonary Disease | Nocturnal hypoxemia, cough, dyspnea; sleep-related hypoventilation | “Does coughing or shortness of breath wake you at night? Do you use oxygen at night?” |
| Benign Prostatic Hyperplasia or Overactive Bladder | Nocturia causing frequent awakenings; may mask underlying sleep apnea | “How many times do you get up to urinate at night? Is this new or worsening?” |
| Menopause | Hot flashes disrupting sleep, increased risk of sleep apnea after menopause | “Do night sweats or hot flashes wake you up? Have your sleep problems started around menopause?” |
| Parkinson Disease | REM sleep behavior disorder (often precedes motor symptoms), insomnia, excessive daytime sleepiness, restless legs | “Have you noticed any tremor, stiffness, or slowness of movement? Any changes in handwriting or sense of smell?” |
Medication and Substance History
Medications That Cause or Worsen Sleep Disturbance
- Stimulants: Methylphenidate, amphetamines, modafinil — insomnia
- Antidepressants: SSRIs (especially fluoxetine), SNRIs, bupropion — insomnia, vivid dreams, restless legs
- Beta-blockers: Propranolol, metoprolol — insomnia, nightmares (lipophilic agents cross blood-brain barrier)
- Corticosteroids: Prednisone, dexamethasone — insomnia, especially with evening dosing
- Decongestants: Pseudoephedrine, phenylephrine — insomnia
- Theophylline: Insomnia, especially at higher levels
- Thyroid hormone: Excessive doses cause insomnia
- Diuretics: Nocturia disrupting sleep
- Dopamine agonists: May cause sleep attacks, insomnia, or augmentation of restless legs
- Antipsychotics: Akathisia causing restlessness; some cause weight gain worsening sleep apnea
Substances Affecting Sleep
- Caffeine: Ask about coffee, tea, energy drinks, soft drinks, chocolate; timing is critical (half-life 5 to 6 hours, longer in some)
- Alcohol: Initial sedation then sleep fragmentation; REM suppression with rebound; tolerance develops
- Nicotine: Stimulant effect; withdrawal during sleep causes arousal; smokers have more sleep-onset insomnia
- Cannabis: May reduce sleep latency initially; suppresses REM; withdrawal causes insomnia
- Cocaine and methamphetamine: Profound insomnia during use; hypersomnia during withdrawal
- Opioids: Sedation but fragment sleep; cause central sleep apnea; withdrawal causes severe insomnia
Prior Sleep Medication Use
- What has been tried before? What worked or did not work?
- Any history of benzodiazepine or Z-drug dependence?
- Current over-the-counter sleep aid use (antihistamines, melatonin)?
Social and Occupational History
| Factor | Relevance | Key Questions |
|---|---|---|
| Occupation | Shift work, long hours, high-stress jobs, safety-sensitive positions (pilots, truck drivers, healthcare workers) | “What are your work hours? Do you work rotating shifts? Does your job require you to be alert for safety?” |
| Living Situation | Noise, light pollution, bed partner’s sleep habits, caregiving responsibilities, shared sleeping space | “Who do you live with? Is your sleeping environment quiet and dark? Do caregiving duties interrupt your sleep?” |
| Life Stressors | Financial stress, relationship problems, bereavement, major life transitions | “Have there been any major stresses or changes in your life recently? When did your sleep problems start in relation to these?” |
| Travel | Frequent time zone changes, jet lag | “Do you travel frequently across time zones for work? How long does it take you to adjust?” |
| Screen Time | Blue light exposure suppresses melatonin; stimulating content increases arousal | “Do you use your phone, tablet, or computer in bed or right before sleep? Do you watch television in the bedroom?” |
Family History
Genetic Components of Sleep Disorders
Several sleep disorders have significant genetic contributions:
- Restless legs syndrome: Approximately 50% have affected first-degree relative; autosomal dominant inheritance patterns identified
- Narcolepsy type 1: Strong HLA-DQB1*06:02 association; 1 to 2% risk in first-degree relatives (40-fold increased)
- Obstructive sleep apnea: Heritability estimated at 40%; family history doubles risk
- Circadian rhythm disorders: Clock gene polymorphisms; familial patterns of morningness or eveningness
- Fatal familial insomnia: Rare prion disease; autosomal dominant
- Chronic insomnia: Twin studies suggest 30 to 40% heritability
Ask: “Does anyone in your family have sleep problems? Has anyone been diagnosed with sleep apnea, restless legs, or narcolepsy?”
4. Physical Examination
A systematic head-to-toe approach for sleep disturbance
Systematic Framework: Use the “Head to Extremities” approach for complete examination of patients presenting with sleep disturbance. While many sleep disorders have normal physical examinations, targeted examination can identify underlying causes, comorbidities, and complications of sleep disorders.
General Inspection
- Appearance: Signs of fatigue (dark circles under eyes, ptosis, reduced alertness); obesity or body habitus; signs of chronic illness
- Alertness and affect: Drowsy appearance; falling asleep during interview; flat affect suggesting depression; anxious demeanor
- Body mass index: Calculate BMI; obesity (BMI greater than 30) significantly increases obstructive sleep apnea risk
- Neck circumference: Greater than 17 inches (43 cm) in men or greater than 16 inches (41 cm) in women suggests increased obstructive sleep apnea risk
- General appearance: Cushingoid features (if on steroids or considering Cushing syndrome); acromegalic features (macroglossia, prognathism increase airway obstruction)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood Pressure | Elevated blood pressure, especially resistant hypertension; lack of nocturnal dipping on ambulatory monitoring | Obstructive sleep apnea is a common cause of resistant hypertension; should be suspected in any patient with difficult-to-control blood pressure |
| Heart Rate | Tachycardia at rest; irregular rhythm | May indicate hyperthyroidism, anxiety, stimulant use; atrial fibrillation associated with obstructive sleep apnea |
| Respiratory Rate | Tachypnea at rest | May indicate underlying cardiopulmonary disease affecting sleep |
| Oxygen Saturation | Resting hypoxemia (less than 94%) | Suggests chronic lung disease; will worsen during sleep; consider overnight oximetry |
| Temperature | Fever | Infection can disrupt sleep; night sweats may indicate infection, malignancy, or menopause |
Head and Neck Examination
This examination is critical for assessing obstructive sleep apnea risk and identifying upper airway abnormalities.
Craniofacial Structure
- Retrognathia (recessed chin): Posterior displacement of mandible narrows airway; increases obstructive sleep apnea risk
- Micrognathia (small jaw): Similar effect; consider in patients without obesity who have sleep apnea symptoms
- Midface hypoplasia: Seen in certain syndromes; contributes to airway narrowing
- High-arched palate: Reduces oral cavity volume; associated with obstructive sleep apnea
Oropharyngeal Examination
| Finding | Description | Significance |
|---|---|---|
| Mallampati Score | Class I: Full visibility of tonsils, uvula, soft palate Class II: Upper half of tonsils, uvula visible Class III: Soft palate, base of uvula visible Class IV: Only hard palate visible | Higher Mallampati score (III or IV) correlates with increased obstructive sleep apnea risk and severity; represents crowded oropharynx |
| Tonsillar Hypertrophy | Grade 0: Absent (removed) Grade 1: Within tonsillar pillars Grade 2: Extend to pillars Grade 3: Extend beyond pillars Grade 4: Touching midline (“kissing tonsils”) | Enlarged tonsils (grade 3 or 4) contribute to airway obstruction; more significant in younger patients |
| Macroglossia | Enlarged tongue with scalloped lateral edges (from pressing against teeth) | Seen in hypothyroidism, acromegaly, amyloidosis, Down syndrome; contributes to airway obstruction |
| Elongated or Edematous Uvula | Uvula hanging low or appearing swollen | May result from snoring-related trauma; contributes to obstruction |
| Dental Examination | Tooth wear, evidence of bruxism | Sleep bruxism is common; may indicate stress or sleep apnea |
Nasal Examination
- Nasal patency: Assess airflow through each nostril; nasal obstruction worsens obstructive sleep apnea
- Septal deviation: May contribute to nasal obstruction
- Turbinate hypertrophy: Inferior turbinate enlargement from allergies or chronic rhinitis
- Nasal polyps: Visible polyps suggest chronic rhinosinusitis; contribute to obstruction
- Allergic stigmata: “Allergic shiners” (dark circles), transverse nasal crease, pale boggy turbinates
Neck Examination
- Neck circumference: Measure at level of cricothyroid membrane; greater than 17 inches in men or greater than 16 inches in women increases obstructive sleep apnea risk
- Thyroid: Goiter may contribute to airway compromise; check for nodules and size
- Lymphadenopathy: May suggest malignancy or infection
- Jugular venous pressure: Elevated in right heart failure (may be consequence of severe obstructive sleep apnea)
Neurological Examination
| Component | What to Assess | Clinical Relevance |
|---|---|---|
| Mental Status | Alertness, attention, concentration, mood, cognitive function | Sleepiness impairs attention; depression and anxiety commonly comorbid; cognitive impairment may indicate sleep deprivation or neurodegenerative disease |
| Cranial Nerves | Particularly IX, X, XII for palate movement, gag reflex, tongue strength | Bulbar weakness can cause central or obstructive sleep apnea; seen in motor neuron disease, stroke, myasthenia gravis |
| Motor Examination | Tone, strength, bulk; look for bradykinesia, rigidity, tremor | Parkinsonism suggests REM sleep behavior disorder may precede motor symptoms; myopathy may cause respiratory muscle weakness |
| Sensory Examination | Light touch, pinprick, vibration in lower extremities | Peripheral neuropathy associated with restless legs syndrome and periodic limb movements |
| Reflexes | Deep tendon reflexes; plantar responses | Hyperreflexia or Babinski sign suggests upper motor neuron pathology |
| Coordination and Gait | Romberg test, tandem gait, finger-to-nose | Ataxia may indicate cerebellar pathology or severe sleep deprivation |
Cardiovascular Examination
- Jugular venous pressure: Elevated in right heart failure; obstructive sleep apnea can cause pulmonary hypertension and cor pulmonale
- Heart sounds: Loud P2 suggests pulmonary hypertension; S3 gallop indicates heart failure
- Murmurs: May indicate structural heart disease
- Peripheral edema: Lower extremity edema suggests heart failure or cor pulmonale; also increases obstructive sleep apnea severity through rostral fluid shift when supine
- Peripheral pulses: Assess for peripheral vascular disease (associated with obstructive sleep apnea)
Respiratory Examination
- Chest wall: Kyphoscoliosis restricts lung expansion; barrel chest suggests chronic obstructive pulmonary disease
- Breath sounds: Wheezing suggests asthma or chronic obstructive pulmonary disease; crackles may indicate heart failure or interstitial lung disease
- Use of accessory muscles: Suggests respiratory distress
- Diaphragmatic excursion: Reduced in diaphragmatic weakness or paralysis (may cause sleep-related hypoventilation)
Abdominal Examination
- Central obesity: Visceral fat contributes to obstructive sleep apnea independently of overall BMI
- Hepatomegaly: May indicate heart failure, fatty liver disease (associated with obstructive sleep apnea)
- Ascites: Elevates diaphragm and worsens respiratory mechanics during sleep
Extremities and Skin
- Peripheral edema: Heart failure, venous insufficiency; fluid redistributes to neck when supine, worsening obstructive sleep apnea
- Cyanosis: Central cyanosis suggests hypoxemia; peripheral cyanosis may indicate poor circulation
- Clubbing: Chronic hypoxemia from severe sleep apnea or underlying lung disease
- Skin changes: Myxedema (hypothyroidism); thin skin and bruising (Cushing syndrome); acanthosis nigricans (insulin resistance)
- Restless legs assessment: Observe for leg discomfort or urge to move during examination; may see involuntary leg movements
Expected Findings by Etiology
| Condition | General | Upper Airway | Other Key Findings |
|---|---|---|---|
| Obstructive Sleep Apnea | Obesity (not always); large neck circumference; hypertension | Crowded oropharynx; high Mallampati; retrognathia; enlarged tonsils; nasal obstruction | Peripheral edema; signs of pulmonary hypertension in severe cases |
| Chronic Insomnia Disorder | Usually normal; may appear fatigued or anxious | Normal | Examination typically normal; may have signs of anxiety or depression |
| Restless Legs Syndrome | Usually normal | Normal | May observe leg restlessness; peripheral neuropathy signs in secondary cases; pallor if iron deficient |
| Narcolepsy | May be obese (orexin involved in metabolism); may appear sleepy | Usually normal | Cataplexy may be observed with strong emotion; otherwise normal neurological examination |
| REM Sleep Behavior Disorder | May have bruises from dream enactment | Normal | Early parkinsonian features (subtle bradykinesia, reduced arm swing, hypomimia, hyposmia); may be normal initially |
| Hypothyroidism | Weight gain, fatigue, cold intolerance | Macroglossia; goiter; periorbital edema | Bradycardia; delayed relaxation of reflexes; dry skin; non-pitting edema |
| Depression | Psychomotor retardation or agitation; poor eye contact; flat affect | Normal | May have weight change; examination typically normal |
| Heart Failure | Dyspnea, fatigue | Normal | Elevated jugular venous pressure; S3 gallop; peripheral edema; pulmonary crackles; displaced apex |
Important Teaching Point
Normal examination is common! Many causes of sleep disturbance present with entirely normal physical examination findings. Chronic insomnia disorder, circadian rhythm disorders, most cases of restless legs syndrome, and many patients with obstructive sleep apnea (especially non-obese individuals) may have unremarkable examinations. A normal examination does not exclude significant pathology—the history and sleep studies remain the cornerstones of diagnosis.
The “thin patient with sleep apnea”: Do not dismiss obstructive sleep apnea in non-obese patients. Craniofacial abnormalities (retrognathia, micrognathia) and upper airway crowding can cause significant sleep apnea in thin individuals. Always examine the airway regardless of body habitus.
Special Assessments
Bedside Tests for Sleepiness
- Observation during interview: Does the patient fall asleep while talking to you or during brief pauses? This indicates severe sleepiness.
- Psychomotor vigilance: Patients with severe sleepiness may have slowed reaction times, difficulty sustaining attention, and microsleeps.
- Provocative testing for cataplexy: In suspected narcolepsy, asking the patient to recall something very funny may trigger subtle facial weakness or knee buckling (use cautiously and with consent).
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Sleep disturbance encompasses a wide spectrum of disorders. The differential diagnosis should be guided by the primary complaint: difficulty initiating or maintaining sleep (insomnia), excessive daytime sleepiness (hypersomnia), or abnormal behaviors during sleep (parasomnias). Many patients have overlapping conditions, and comorbidity is the rule rather than the exception.
Insomnia (Difficulty Sleeping)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Chronic Insomnia Disorder | Difficulty initiating or maintaining sleep; adequate sleep opportunity; daytime impairment; duration greater than 3 months; often with conditioned arousal | Suicidal ideation; severe functional impairment |
| COMMON | Insomnia due to Psychiatric Disorder (Depression, Anxiety) | Sleep disturbance with mood symptoms; early morning awakening (depression); difficulty falling asleep with racing thoughts (anxiety) | Suicidal ideation; psychotic features; severe weight loss |
| COMMON | Poor Sleep Hygiene | Irregular sleep schedule; excessive caffeine or screen time; using bed for non-sleep activities; daytime napping | None specific |
| COMMON | Insomnia due to Medical Condition | Pain, dyspnea, nocturia, pruritus, or other symptoms disrupting sleep; sleep improves when medical condition controlled | Depends on underlying condition |
| LESS COMMON (approximately 20%) | Obstructive Sleep Apnea (presenting as insomnia) | Sleep-maintenance insomnia; frequent awakenings; nocturia; may not report typical snoring or witnessed apneas | Excessive daytime sleepiness; hypertension |
| LESS COMMON | Restless Legs Syndrome | Urge to move legs with uncomfortable sensations; worse at rest and in evening; relief with movement; sleep-onset insomnia | Severe anemia; renal failure |
| LESS COMMON | Circadian Rhythm Sleep-Wake Disorders | Delayed or advanced sleep phase; shift work disorder; jet lag; irregular sleep-wake pattern | Associated cognitive decline (irregular rhythm) |
| LESS COMMON | Medication or Substance-Induced Insomnia | Temporal relationship to medication initiation; common culprits include stimulants, antidepressants, steroids, beta-blockers | Substance abuse; withdrawal symptoms |
| UNCOMMON BUT SERIOUS (approximately 10%) | Paradoxical Insomnia (Sleep State Misperception) | Severe complaint of insomnia with near-normal sleep on polysomnography; significant distress despite objective findings | Assess for psychiatric comorbidity |
| UNCOMMON BUT SERIOUS | Central Sleep Apnea | Frequent awakenings; witnessed apneas without snoring; associated with heart failure, opioid use, or stroke | Heart failure symptoms; neurological deficits |
Excessive Daytime Sleepiness (Hypersomnia)
Step-by-Step Approach to Excessive Daytime Sleepiness:
- Step 1: Rule out insufficient sleep — Is the patient getting adequate sleep opportunity (at least 7 hours)?
- Step 2: Consider sleep-disordered breathing — Does the patient snore, have witnessed apneas, or risk factors for obstructive sleep apnea?
- Step 3: Evaluate for medical, psychiatric, and medication causes
- Step 4: Consider central disorders of hypersomnolence — Narcolepsy, idiopathic hypersomnia
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Insufficient Sleep Syndrome | Most common cause overall | Habitually short sleep duration; sleepiness resolves with extended sleep; often associated with work or social demands |
| COMMON | Obstructive Sleep Apnea | Affects 10 to 30% of adults; most common medical cause | Snoring; witnessed apneas; obesity; large neck; hypertension; nocturia; morning headaches |
| COMMON | Medication-Induced Sleepiness | Very common in clinical practice | Temporal relationship to medication; common culprits: antihistamines, benzodiazepines, opioids, antipsychotics, antiepileptics |
| COMMON | Depression | 30% of depressed patients report hypersomnia | Low mood; anhedonia; fatigue distinct from sleepiness; atypical depression features |
| LESS COMMON | Narcolepsy Type 1 (with cataplexy) | 0.02 to 0.05% prevalence | Cataplexy (pathognomonic); sleep paralysis; hypnagogic hallucinations; disrupted nocturnal sleep; onset typically adolescence |
| LESS COMMON | Narcolepsy Type 2 (without cataplexy) | Similar to Type 1 | Excessive daytime sleepiness without cataplexy; positive multiple sleep latency test; normal cerebrospinal fluid orexin |
| LESS COMMON | Idiopathic Hypersomnia | Rare; less common than narcolepsy | Prolonged sleep time (often greater than 10 hours); severe sleep inertia (“sleep drunkenness”); unrefreshing naps; no cataplexy |
| LESS COMMON | Periodic Limb Movement Disorder | 4% prevalence; increases with age | Repetitive limb movements during sleep; bed partner reports kicking; unrefreshing sleep; diagnosed on polysomnography |
| UNCOMMON BUT SERIOUS | Central Nervous System Pathology | Rare | Brain tumor, stroke, encephalitis, multiple sclerosis involving hypothalamus or brainstem; new neurological symptoms |
| UNCOMMON BUT SERIOUS | Kleine-Levin Syndrome | Very rare (1 to 5 per million) | Recurrent episodes of severe hypersomnia lasting days to weeks; hyperphagia; hypersexuality; cognitive changes; normal between episodes |
Parasomnias (Abnormal Behaviors During Sleep)
| Category | Condition | Sleep Stage | Key Features |
|---|---|---|---|
| NREM Parasomnias | Sleepwalking (Somnambulism) | N3 (slow-wave sleep) | Complex behaviors while asleep; amnesia for events; typically first third of night; more common in children; may be triggered by sleep deprivation |
| NREM Parasomnias | Sleep Terrors | N3 (slow-wave sleep) | Sudden arousal with screaming, fear, autonomic activation; inconsolable; amnesia; typically first third of night |
| NREM Parasomnias | Confusional Arousals | N3 (slow-wave sleep) | Disorientation and confusion upon awakening; automatic behaviors; amnesia; more common in children |
| NREM Parasomnias | Sleep-Related Eating Disorder | N3 (slow-wave sleep) | Eating during partial arousal; amnesia; may eat unusual items; associated with sedative use |
| REM Parasomnias | REM Sleep Behavior Disorder | REM sleep | Dream enactment; loss of REM atonia; vivid violent dreams; may cause injury; typically last third of night; strong association with synucleinopathies |
| REM Parasomnias | Nightmare Disorder | REM sleep | Recurrent disturbing dreams with full awakening and recall; typically last third of night; associated with PTSD, stress, medications |
| REM Parasomnias | Sleep Paralysis (Isolated) | REM sleep transitions | Inability to move upon falling asleep or awakening; full awareness; often frightening; may occur with narcolepsy or in isolation |
| Other | Sleep-Related Bruxism | Any stage | Teeth grinding during sleep; jaw pain; tooth wear; may be associated with sleep apnea or stress |
| Other | Sleep Enuresis | Any stage | Involuntary urination during sleep; primary (lifelong) or secondary (new onset—evaluate for underlying cause) |
Etiological Approach
Primary Sleep Disorders
Chronic Insomnia Disorder
Obstructive Sleep Apnea
Central Sleep Apnea
Restless Legs Syndrome
Periodic Limb Movement Disorder
Narcolepsy Types 1 and 2
Idiopathic Hypersomnia
Circadian Rhythm Disorders
Parasomnias (NREM and REM)
Psychiatric Disorders
Major Depressive Disorder
Generalized Anxiety Disorder
Post-Traumatic Stress Disorder
Bipolar Disorder
Panic Disorder
Schizophrenia
Substance Use Disorders
Adjustment Disorder
Medical Conditions
Chronic Pain Syndromes
Heart Failure
Chronic Obstructive Pulmonary Disease
Gastroesophageal Reflux Disease
Hyperthyroidism
Hypothyroidism
Chronic Kidney Disease
Parkinson Disease
Dementia
Nocturia (various causes)
Medications and Substances
Caffeine
Alcohol
Nicotine
Stimulants
Antidepressants (SSRIs, SNRIs)
Beta-Blockers
Corticosteroids
Decongestants
Sedative Withdrawal
Cannabis
Drug-Induced Sleep Disturbance
| Drug or Drug Class | Type of Sleep Disturbance | Mechanism | Time to Resolution After Stopping |
|---|---|---|---|
| Selective Serotonin Reuptake Inhibitors (SSRIs) | Insomnia; vivid dreams; restless legs; periodic limb movements | Serotonergic effects on sleep architecture; reduced REM; dopamine effects on movement | Days to weeks; may need to switch agents |
| Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) | Insomnia; similar to SSRIs | Noradrenergic activation adds to insomnia risk | Days to weeks |
| Bupropion | Insomnia; vivid dreams | Dopamine and norepinephrine reuptake inhibition | Days to weeks; consider morning dosing |
| Beta-Blockers (lipophilic) | Insomnia; nightmares; vivid dreams | Central nervous system penetration; melatonin suppression | Days; switch to hydrophilic agent (atenolol) |
| Corticosteroids | Insomnia; early morning awakening | Stimulant effect; disruption of hypothalamic-pituitary-adrenal axis | Days after dose reduction; give morning doses |
| Stimulants (methylphenidate, amphetamines) | Sleep-onset insomnia | Dopamine and norepinephrine increase; prolonged alertness | Hours to days depending on formulation |
| Theophylline | Insomnia | Adenosine antagonism (similar to caffeine) | Days; dose-dependent |
| Decongestants (pseudoephedrine) | Insomnia | Sympathomimetic stimulation | Hours; avoid evening dosing |
| Thyroid Hormone (excess) | Insomnia; shortened sleep | Hypermetabolic state | Weeks; adjust dose to normalize thyroid function |
| Dopamine Agonists | Insomnia; sleep attacks; augmentation of restless legs | Dopaminergic effects vary by receptor and dose | Variable; augmentation may be irreversible |
| Opioids | Central sleep apnea; disrupted sleep architecture | Respiratory depression; reduced REM and slow-wave sleep | Dose-dependent; may persist with chronic use |
| Alcohol | Initial sedation then sleep fragmentation; REM rebound | GABA potentiation acutely; withdrawal effects as metabolized | Metabolism in 4 to 6 hours triggers fragmentation |
| Benzodiazepines and Z-drugs (withdrawal) | Severe rebound insomnia | GABA receptor downregulation; hyperexcitability on withdrawal | Days to weeks; taper slowly |
| Antihistamines (first generation) | Daytime sedation; tolerance develops to sleep effects | Central histamine blockade | Hours; not recommended for chronic insomnia |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Snoring with witnessed apneas and daytime sleepiness | Obstructive Sleep Apnea | Home sleep apnea test or polysomnography |
| Leg discomfort at rest relieved by movement | Restless Legs Syndrome | Check ferritin; consider dopamine agonist trial |
| Irresistible sleepiness with sudden muscle weakness during laughter | Narcolepsy Type 1 | Polysomnography followed by multiple sleep latency test |
| Acting out dreams with potential for injury | REM Sleep Behavior Disorder | Polysomnography; screen for parkinsonism; bedroom safety |
| Cannot fall asleep at conventional time but sleeps well if allowed late schedule | Delayed Sleep-Wake Phase Disorder | Sleep diary; consider light therapy and melatonin |
| Early morning awakening with low mood and anhedonia | Major Depressive Disorder | Depression screening; psychiatric evaluation |
| Sleep disturbance with palpitations, weight loss, heat intolerance | Hyperthyroidism | Check thyroid-stimulating hormone |
| Resistant hypertension with daytime fatigue | Obstructive Sleep Apnea | Sleep study; high index of suspicion even without typical symptoms |
| Insomnia starting after new medication | Drug-Induced Insomnia | Review medication timing and necessity; consider alternatives |
| Partner reports rhythmic leg jerking during sleep | Periodic Limb Movement Disorder | Polysomnography for confirmation |
| Excessive sleepiness with very long sleep time and severe sleep inertia | Idiopathic Hypersomnia | Polysomnography and multiple sleep latency test; exclude other causes |
| New-onset sleepwalking in adult | Consider underlying trigger: sleep apnea, medication, alcohol | Evaluate for comorbid sleep disorder; review medications |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The investigation of sleep disturbance should be guided by the clinical history and examination. Not all patients require sleep studies—many cases of insomnia can be diagnosed clinically. However, when sleep-disordered breathing, narcolepsy, or parasomnias are suspected, objective testing becomes essential.
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Sleep Diary (1 to 2 weeks) | Document sleep patterns; essential before diagnosing insomnia or circadian disorders | Bedtime, wake time, sleep latency, number of awakenings, naps, sleep quality ratings | Gold standard for insomnia assessment; free; reveals patterns not apparent from history alone |
| Epworth Sleepiness Scale | Quantify daytime sleepiness | Score greater than 10 indicates excessive sleepiness; greater than 15 is severe | Quick screening tool; helps track treatment response; does not replace objective testing |
| Complete Blood Count | Screen for anemia (associated with restless legs syndrome) | Hemoglobin, hematocrit, mean corpuscular volume | Low hemoglobin may worsen restless legs; investigate cause if anemic |
| Ferritin | Assess iron stores; critical in restless legs syndrome | Target ferritin greater than 75 micrograms per liter for restless legs syndrome | Check even if hemoglobin is normal; low ferritin is common and treatable cause |
| Thyroid-Stimulating Hormone | Screen for thyroid dysfunction | Hypothyroidism causes fatigue and sleepiness; hyperthyroidism causes insomnia | Low threshold to check; common and easily treated |
| Comprehensive Metabolic Panel | Screen for renal and hepatic dysfunction | Uremia worsens restless legs; liver disease affects medication metabolism | Consider in all patients with unexplained sleep disturbance |
| Fasting Glucose or Hemoglobin A1c | Screen for diabetes mellitus | Diabetes associated with obstructive sleep apnea, nocturia, neuropathy | Bidirectional relationship; sleep apnea worsens glucose control |
Targeted Investigations by Suspected Etiology
If Suspecting Obstructive Sleep Apnea
First-Line Tests
- Home Sleep Apnea Test (HSAT): Portable monitoring measuring airflow, respiratory effort, and oxygen saturation; appropriate for patients with high pretest probability and no significant comorbidities
- Interpretation: Apnea-Hypopnea Index (AHI) of 5 to 15 = mild; 15 to 30 = moderate; greater than 30 = severe obstructive sleep apnea
- Limitation: May underestimate severity; cannot detect other sleep disorders
Second-Line Tests
- In-Laboratory Polysomnography: Gold standard; required if home test negative but clinical suspicion remains high, if comorbid conditions present (heart failure, chronic lung disease, neuromuscular disease), or if CPAP titration needed
- Split-Night Study: Diagnostic study first half, CPAP titration second half if AHI greater than 40 in first 2 hours
If Suspecting Narcolepsy or Idiopathic Hypersomnia
Required Testing
- Polysomnography: Must precede multiple sleep latency test; excludes other causes of sleepiness; ensures adequate sleep opportunity (at least 6 hours)
- Multiple Sleep Latency Test (MSLT): Series of 5 nap opportunities at 2-hour intervals; measures mean sleep latency and presence of sleep-onset REM periods
- Interpretation: Mean sleep latency less than 8 minutes with 2 or more sleep-onset REM periods suggests narcolepsy; less than 8 minutes without sleep-onset REM periods suggests idiopathic hypersomnia
Adjunctive Tests
- HLA Typing: HLA-DQB1*06:02 positive in greater than 95% of narcolepsy type 1; not diagnostic alone (present in 25% of general population)
- Cerebrospinal Fluid Orexin (Hypocretin-1): Level less than 110 picograms per milliliter is diagnostic for narcolepsy type 1; invasive but highly specific; useful when clinical picture unclear
- Actigraphy: Wrist-worn device measuring movement; confirms sleep schedule before testing; useful for 1 to 2 weeks before sleep study
If Suspecting Restless Legs Syndrome
Essential Testing
- Serum Ferritin: Target greater than 75 micrograms per liter; supplementation often improves symptoms even without anemia
- Iron Studies: Serum iron, total iron-binding capacity, transferrin saturation if ferritin borderline
- Complete Blood Count: Exclude anemia
- Renal Function: Chronic kidney disease is common secondary cause
When to Consider Polysomnography
- Atypical presentation or diagnostic uncertainty
- Suspected comorbid periodic limb movement disorder
- Lack of response to treatment
- Suspected comorbid sleep apnea
Note: Polysomnography is not required for typical restless legs syndrome diagnosis; clinical criteria are sufficient
If Suspecting REM Sleep Behavior Disorder
Required Testing
- Video Polysomnography: Essential for diagnosis; demonstrates REM sleep without atonia and complex motor behaviors during REM
- Electromyography during REM: Increased chin EMG tone or excessive limb EMG activity during REM sleep
Neurological Evaluation
- Detailed Neurological Examination: Screen for early parkinsonism (bradykinesia, rigidity, reduced arm swing, hypomimia)
- Olfactory Testing: Hyposmia is early marker of synucleinopathy
- Consider MRI Brain: If secondary cause suspected or neurological signs present
- Long-term Follow-up: Greater than 80% will develop Parkinson disease, dementia with Lewy bodies, or multiple system atrophy within 10 to 15 years
If Suspecting Circadian Rhythm Disorder
First-Line Assessment
- Sleep Diary (minimum 2 weeks): Documents sleep-wake pattern; essential for diagnosis
- Actigraphy (7 to 14 days): Objective measure of rest-activity patterns; worn on wrist; confirms circadian pattern
Advanced Testing (rarely needed)
- Dim Light Melatonin Onset: Measures timing of endogenous melatonin secretion; research tool; not routinely available
- Core Body Temperature Monitoring: Circadian marker; research applications
Understanding Polysomnography
| Parameter | What It Measures | Clinical Significance |
|---|---|---|
| Apnea-Hypopnea Index (AHI) | Number of apneas and hypopneas per hour of sleep | Less than 5 = normal; 5 to 15 = mild; 15 to 30 = moderate; greater than 30 = severe sleep apnea |
| Respiratory Disturbance Index (RDI) | AHI plus respiratory effort-related arousals per hour | May be elevated when AHI is normal; captures upper airway resistance syndrome |
| Oxygen Desaturation Index | Number of 3% or 4% oxygen desaturations per hour | Correlates with cardiovascular risk; may be elevated in central apnea |
| Minimum Oxygen Saturation | Lowest oxygen level during study | Nadir below 80% indicates severe desaturation |
| Sleep Efficiency | Percentage of time in bed spent asleep | Greater than 85% is normal; low efficiency seen in insomnia |
| Sleep Latency | Time from lights out to sleep onset | Greater than 30 minutes suggests sleep-onset insomnia |
| REM Latency | Time from sleep onset to first REM period | Shortened (less than 15 minutes) in narcolepsy and depression |
| Arousal Index | Number of arousals per hour of sleep | Elevated in sleep apnea, periodic limb movements; greater than 25 is abnormal |
| Periodic Limb Movement Index | Number of periodic limb movements per hour | Greater than 15 with associated arousals is clinically significant |
| REM Without Atonia | Presence of muscle tone during REM sleep | Diagnostic of REM sleep behavior disorder |
Empiric Treatment Trials as Diagnostic Tools
When History Strongly Suggests Diagnosis
In some cases, empiric treatment trials can serve as diagnostic tools when the clinical picture is clear but objective testing is unavailable, impractical, or would delay necessary treatment.
- Restless Legs Syndrome: If ferritin is low, trial of iron supplementation (ferrous sulfate 325 mg with vitamin C on empty stomach); improvement within 6 to 12 weeks supports diagnosis
- Restless Legs Syndrome with normal ferritin: Brief trial of low-dose dopamine agonist (pramipexole 0.125 mg or ropinirole 0.25 mg); rapid response supports diagnosis
- Chronic Insomnia Disorder: Trial of cognitive behavioral therapy for insomnia (CBT-I); sustained improvement confirms behavioral perpetuating factors
- Circadian Rhythm Disorder (Delayed Phase): Trial of melatonin 0.5 to 3 mg given 5 to 6 hours before desired bedtime plus morning bright light therapy; phase advance confirms diagnosis
- Gastroesophageal Reflux-Related Sleep Disturbance: Trial of proton pump inhibitor twice daily for 4 to 8 weeks; improvement in sleep supports diagnosis
When to Refer to Sleep Medicine Specialist
Indications for Specialist Referral
- Suspected narcolepsy or idiopathic hypersomnia: Requires multiple sleep latency test interpretation and specialized management
- REM sleep behavior disorder: Needs video polysomnography; neurodegenerative disease counseling
- Complex sleep apnea: Central apnea emerging on CPAP; treatment-emergent central apnea
- CPAP failure or intolerance: Alternative therapies (oral appliances, surgery, hypoglossal nerve stimulation) require specialist evaluation
- Refractory insomnia: Failed first-line treatments including cognitive behavioral therapy
- Parasomnias with injury risk: Sleepwalking, sleep terrors, or REM sleep behavior disorder causing harm
- Suspected central disorders of hypersomnolence: Unexplained excessive daytime sleepiness despite adequate sleep
- Occupational safety concerns: Pilots, commercial drivers, heavy machinery operators with sleep disorders
Investigation Algorithm
Step-by-Step Approach to Sleep Investigation:
- All patients: Sleep diary; Epworth Sleepiness Scale; basic labs (CBC, ferritin, TSH, metabolic panel)
- If excessive daytime sleepiness with snoring or apneas: Home sleep apnea test (or polysomnography if comorbidities present)
- If excessive daytime sleepiness without sleep apnea features: Polysomnography followed by multiple sleep latency test
- If leg symptoms at rest: Ferritin and iron studies; consider empiric treatment; polysomnography if atypical
- If dream enactment behaviors: Video polysomnography; neurological evaluation
- If circadian pattern suspected: 2-week sleep diary and actigraphy
- If insomnia without red flags: Clinical diagnosis; sleep diary; consider empiric CBT-I
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Severe sleepiness with recent motor vehicle accident or near-miss | EMERGENT | Advise patient not to drive; expedite sleep study; consider fitness-to-drive assessment; document counseling |
| Insomnia with active suicidal ideation | EMERGENT | Psychiatric emergency assessment; insomnia is independent risk factor for suicide; do not discharge without safety plan |
| Witnessed apneas with severe hypoxemia or arrhythmia | EMERGENT | Urgent sleep study; consider inpatient monitoring if severe; may need urgent CPAP initiation |
| REM sleep behavior disorder with injury to patient or bed partner | URGENT | Implement bedroom safety measures immediately; expedite video polysomnography; consider empiric clonazepam or melatonin |
| New-onset cataplexy or sudden-onset hypersomnia | URGENT | Urgent neurology or sleep medicine referral; consider brain MRI to exclude secondary causes; driving restriction |
| Severe insomnia with new weight loss or night sweats | URGENT | Evaluate for occult malignancy, infection, or hyperthyroidism; comprehensive workup indicated |
| Obstructive sleep apnea with uncontrolled hypertension or heart failure | URGENT | Expedite sleep study; early CPAP initiation may improve cardiovascular outcomes |
| Chronic insomnia affecting work or quality of life | ROUTINE | Sleep diary; sleep hygiene education; consider cognitive behavioral therapy for insomnia referral |
| Mild snoring without daytime symptoms | ROUTINE | STOP-BANG questionnaire; consider home sleep test if risk factors present; lifestyle modification |
| Restless legs symptoms without significant sleep disruption | ROUTINE | Check ferritin; trial of iron supplementation if low; sleep hygiene; follow up in 6 to 8 weeks |
Step 2: Classify by Primary Complaint
Cannot Sleep (Insomnia)
Difficulty initiating, maintaining, or non-restorative sleep
→ Proceed to Algorithm A
Too Sleepy (Hypersomnia)
Excessive daytime sleepiness despite adequate sleep opportunity
→ Proceed to Algorithm B
Abnormal Behaviors (Parasomnia)
Unusual movements, behaviors, or experiences during sleep
→ Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Insomnia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Insomnia less than 2 weeks with identifiable stressor | Acute (Adjustment) Insomnia | Reassurance; sleep hygiene; address stressor; short-term hypnotic only if severe (limit to 1 week) |
| Insomnia greater than 3 months with worry about sleep and conditioned arousal | Chronic Insomnia Disorder | Sleep diary; refer for cognitive behavioral therapy for insomnia (first-line); avoid long-term hypnotics |
| Sleep-onset insomnia with racing thoughts, daytime anxiety | Insomnia comorbid with Anxiety Disorder | Screen with GAD-7; treat anxiety; CBT-I if insomnia persists; consider SSRI (may initially worsen insomnia) |
| Early morning awakening with low mood, anhedonia | Insomnia comorbid with Depression | Screen with PHQ-9; treat depression; sedating antidepressant (mirtazapine, trazodone) may help both |
| Cannot fall asleep at conventional time; sleeps well if allowed late schedule | Delayed Sleep-Wake Phase Disorder | Sleep diary and actigraphy; morning bright light therapy; evening melatonin 0.5 to 3 mg (5 to 6 hours before desired bedtime) |
| Insomnia with leg discomfort at rest relieved by movement | Restless Legs Syndrome | Check ferritin (target greater than 75); iron supplementation if low; consider dopamine agonist or alpha-2-delta ligand |
| Sleep-maintenance insomnia with snoring or obesity | Possible Obstructive Sleep Apnea | STOP-BANG questionnaire; home sleep test or polysomnography; do not attribute to insomnia without excluding apnea |
| Insomnia temporally related to new medication | Medication-Induced Insomnia | Review medication list; adjust timing (morning for stimulating drugs); consider alternatives; avoid reflexive hypnotic addition |
| Insomnia with chronic pain | Insomnia comorbid with Chronic Pain | Optimize pain management; CBT-I effective even with pain; consider duloxetine or low-dose tricyclic if both conditions present |
Algorithm B: Excessive Daytime Sleepiness
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Sleepiness with inadequate sleep time (less than 7 hours habitually) | Insufficient Sleep Syndrome | Sleep diary confirming short sleep; counsel on sleep extension; symptoms should resolve within 1 to 2 weeks of adequate sleep |
| Sleepiness with snoring, witnessed apneas, obesity, hypertension | Obstructive Sleep Apnea | Home sleep test or polysomnography; CPAP titration; counsel on driving risk; weight loss; positional therapy if appropriate |
| Sleepiness with heart failure, opioid use, or stroke history | Central Sleep Apnea | In-laboratory polysomnography (not home test); treat underlying condition; CPAP, adaptive servo-ventilation, or supplemental oxygen depending on type |
| Severe sleepiness with cataplexy (muscle weakness with emotion) | Narcolepsy Type 1 | Polysomnography plus MSLT; driving restriction; stimulants (modafinil, methylphenidate); sodium oxybate for cataplexy; specialist referral |
| Severe sleepiness without cataplexy; sleep-onset REM on MSLT | Narcolepsy Type 2 | Exclude other causes; stimulant therapy; regular sleep schedule; scheduled naps; specialist management |
| Sleepiness with very long sleep time (greater than 10 hours), severe sleep inertia, unrefreshing naps | Idiopathic Hypersomnia | Polysomnography plus MSLT; mean sleep latency less than 8 minutes without sleep-onset REM; stimulants; specialist referral |
| Sleepiness on sedating medications | Medication-Induced Sleepiness | Review all medications; reduce dose or switch to less sedating alternatives; avoid adding stimulants to counteract sedation |
| Sleepiness with shift work schedule | Shift Work Sleep Disorder | Sleep diary; strategic napping; bright light during shift; melatonin before daytime sleep; consider modafinil if severe |
Algorithm C: Parasomnias
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Sleepwalking or sleep terrors in first third of night; amnesia for events; child or young adult | NREM Parasomnia (Disorders of Arousal) | Reassurance if infrequent; safety measures; address triggers (sleep deprivation, alcohol); consider clonazepam if dangerous behaviors |
| New-onset sleepwalking in adult | Consider secondary cause | Evaluate for obstructive sleep apnea (common trigger); review medications (zolpidem, SSRIs); polysomnography recommended |
| Acting out dreams; violent behavior during sleep; typically second half of night; older adult | REM Sleep Behavior Disorder | Video polysomnography; bedroom safety essential; melatonin 3 to 12 mg or clonazepam 0.5 to 2 mg; neurological follow-up for synucleinopathy |
| Recurrent nightmares with full awakening and recall; history of trauma | Nightmare Disorder (often PTSD-related) | Trauma-focused therapy; prazosin 1 to 15 mg at bedtime; imagery rehearsal therapy; review medications (beta-blockers, SSRIs can cause nightmares) |
| Inability to move upon awakening; full awareness; frightening | Isolated Sleep Paralysis | Reassurance; improve sleep habits; if recurrent with other symptoms, evaluate for narcolepsy |
| Eating during partial arousal; amnesia; weight gain | Sleep-Related Eating Disorder | Review medications (zolpidem is common cause); treat underlying sleep disorders; consider topiramate |
| Teeth grinding during sleep; jaw pain; tooth wear | Sleep-Related Bruxism | Dental evaluation for occlusal splint; evaluate for sleep apnea (associated); stress management; avoid caffeine and alcohol |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient requests sleeping pills for chronic insomnia | Acknowledge distress; explain that CBT-I is more effective long-term than medications | Refer for CBT-I; if pharmacotherapy needed, use lowest dose for shortest duration; avoid benzodiazepines if possible |
| Patient is taking benzodiazepine for years and wants to stop | Commend decision; explain tapering process to prevent rebound and withdrawal | Gradual taper (reduce by 10 to 25% every 1 to 2 weeks); concurrent CBT-I improves success; may take months |
| Patient with sleep apnea cannot tolerate CPAP | Identify specific barriers (mask fit, pressure, claustrophobia, dryness) | Mask refitting; humidification; pressure adjustment; if still intolerant, refer for oral appliance or surgical evaluation |
| Patient has drowsy driving but refuses to stop driving | Document discussion clearly; explain legal and safety risks; involve family if patient consents | Know your jurisdiction’s reporting requirements; expedite workup; consider fitness-to-drive evaluation |
| Ferritin is 50 in patient with restless legs syndrome | Supplement iron despite “normal” ferritin; target greater than 75 for restless legs syndrome | Ferrous sulfate 325 mg with vitamin C on empty stomach; recheck ferritin in 3 months; expect improvement in 6 to 12 weeks |
| Patient with REM sleep behavior disorder asks about prognosis | Discuss association with neurodegenerative disease honestly but sensitively | Explain that more than 80% develop synucleinopathy over 10 to 15 years; offer neurological follow-up; discuss research opportunities |
| Young patient cannot wake up for school or work | Suspect delayed sleep-wake phase disorder; obtain sleep diary | Confirm pattern with actigraphy; morning bright light therapy; evening melatonin; gradual schedule advancement |
| Patient reports severe insomnia but polysomnography shows normal sleep | Consider paradoxical insomnia (sleep state misperception); validate patient’s distress | CBT-I is still effective; address catastrophic beliefs about sleep; reassure that objective sleep is adequate |
| Bed partner reports loud snoring but patient has no symptoms | Screen for cardiovascular risk factors; asymptomatic sleep apnea still causes harm | Home sleep test; treat if AHI greater than 15 or if cardiovascular disease present even without symptoms |
| Patient with restless legs getting worse on dopamine agonist | Suspect augmentation (symptoms earlier, more intense, spreading to arms) | Taper and discontinue dopamine agonist slowly; switch to alpha-2-delta ligand (gabapentin, pregabalin); specialist referral |
Troubleshooting Refractory Sleep Disturbance
Ask These Questions When Treatment Fails
- Is the diagnosis correct? Reconsider differential; did we miss sleep apnea in an “insomnia” patient? Did we miss restless legs syndrome?
- Are there multiple overlapping causes? Comorbidity is common (for example, sleep apnea plus insomnia plus depression); all must be addressed
- Was treatment adequate? Was CBT-I completed (typically 6 to 8 sessions)? Was CPAP used consistently (at least 4 hours per night)?
- Is there treatment-interfering behavior? Continued caffeine use? Irregular sleep schedule? Using bed for non-sleep activities?
- Are medications contributing? Re-review all medications for sleep effects; include over-the-counter and supplements
- Is there an untreated psychiatric condition? Depression and anxiety perpetuate insomnia; substance use undermines all treatments
- Does the patient have unrealistic expectations? Older adults may expect to sleep like they did at age 20; some decline in sleep quality is normal with aging
- Is specialist referral needed? Complex or refractory cases benefit from sleep medicine expertise
Treatment Principles by Diagnosis
| Diagnosis | First-Line Treatment | Second-Line Treatment | Key Points |
|---|---|---|---|
| Chronic Insomnia Disorder | Cognitive Behavioral Therapy for Insomnia (CBT-I) | Pharmacotherapy if CBT-I unavailable or failed: low-dose doxepin, suvorexant, lemborexant, or short-term Z-drug | CBT-I has longer-lasting effects than medications; avoid benzodiazepines; address perpetuating factors |
| Obstructive Sleep Apnea | Continuous Positive Airway Pressure (CPAP) | Oral appliance (mandibular advancement device); weight loss; positional therapy; upper airway surgery; hypoglossal nerve stimulation | CPAP is most effective but adherence is challenging; alternatives for intolerant patients |
| Restless Legs Syndrome | Iron supplementation if ferritin less than 75; alpha-2-delta ligand (gabapentin, pregabalin) | Low-dose dopamine agonist (with augmentation counseling); opioids for refractory cases | Avoid dopamine agonists as first-line due to augmentation risk; always check and treat iron deficiency |
| Narcolepsy Type 1 | Modafinil or armodafinil for sleepiness; sodium oxybate for cataplexy and sleep consolidation | Methylphenidate or amphetamines; pitolisant; solriamfetol | Requires specialist management; scheduled naps helpful; driving restrictions until controlled |
| Delayed Sleep-Wake Phase Disorder | Morning bright light therapy (10,000 lux for 30 minutes upon awakening); evening melatonin (0.5 to 3 mg, 5 to 6 hours before desired bedtime) | Chronotherapy (progressive delay); specialist referral for refractory cases | Must maintain consistent schedule including weekends; light timing is critical |
| REM Sleep Behavior Disorder | Bedroom safety measures; melatonin 3 to 12 mg at bedtime | Clonazepam 0.5 to 2 mg at bedtime | Counsel about neurodegenerative disease risk; neurological follow-up essential |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
CBT-I outperforms medications for chronic insomnia: Cognitive behavioral therapy for insomnia is more effective than sleeping pills in the long term and has no risk of dependence. It should be offered to every patient with chronic insomnia before or instead of pharmacotherapy.
Obstructive sleep apnea does not require obesity: Craniofacial anatomy (retrognathia, crowded oropharynx) can cause significant sleep apnea in thin patients. Always examine the airway regardless of body mass index.
Ferritin target in restless legs syndrome is greater than 75: Standard laboratory “normal” ranges (often greater than 12 or 20) are inadequate for restless legs syndrome. Supplement iron even with “normal” ferritin if symptoms are present and ferritin is below 75.
REM sleep behavior disorder predicts neurodegeneration: More than 80% of patients with idiopathic REM sleep behavior disorder will develop Parkinson disease, dementia with Lewy bodies, or multiple system atrophy within 10 to 15 years. Early diagnosis enables counseling and potential enrollment in neuroprotection trials.
Insomnia is an independent suicide risk factor: Sleep disturbance increases suicide risk independent of depression. Always screen for suicidal ideation in insomnia patients, especially those with psychiatric comorbidity.
Sleep apnea can present as insomnia: Frequent awakenings and sleep-maintenance insomnia may be the primary complaint in obstructive sleep apnea. Do not prescribe hypnotics for insomnia without considering sleep-disordered breathing, especially in patients with risk factors.
The sleep diary is underused and invaluable: A 1 to 2 week sleep diary is free, reveals patterns invisible to history alone, and is essential before diagnosing insomnia or circadian rhythm disorders. Make it routine.
Comorbidity is the rule, not the exception: Most patients with sleep disturbance have multiple contributing factors. Treating only one cause (for example, prescribing CPAP but ignoring comorbid insomnia) often leads to incomplete improvement.
Critical Pitfalls to Avoid
Prescribing long-term benzodiazepines for insomnia: Benzodiazepines lose efficacy over weeks, cause dependence, impair memory, increase fall risk in elderly, and cause rebound insomnia on discontinuation. Use only for short-term crisis management if at all.
Missing obstructive sleep apnea in the “insomnia” patient: Reflexively prescribing hypnotics for insomnia without screening for sleep apnea can worsen apnea severity and mask a treatable condition. Always assess for snoring, witnessed apneas, and risk factors.
Using first-generation antihistamines for chronic insomnia: Diphenhydramine and similar agents cause tolerance, anticholinergic side effects, cognitive impairment in elderly, and next-day sedation. They are not appropriate for chronic insomnia.
Starting dopamine agonists first-line for restless legs syndrome: Dopamine agonists cause augmentation (worsening of symptoms) in up to 70% of patients with long-term use. Iron supplementation and alpha-2-delta ligands should be tried first.
Ignoring medication causes of sleep disturbance: Many common medications disrupt sleep. Adding a hypnotic to counteract insomnia from a stimulating antidepressant is inferior to adjusting the offending medication.
Attributing sleep changes in elderly to “normal aging”: While some sleep changes are normal with aging, significant insomnia, excessive sleepiness, or new-onset parasomnias warrant evaluation. Sleep apnea prevalence increases with age; restless legs syndrome and REM sleep behavior disorder are more common in older adults.
Forgetting to counsel about driving safety: Patients with untreated sleep apnea, narcolepsy, or severe insomnia have significantly increased accident risk. Document counseling and know local reporting requirements.
Dismissing paradoxical insomnia as “not real”: Patients with sleep state misperception genuinely suffer despite near-normal objective sleep. Their distress is real, and CBT-I is effective. Invalidating their experience damages the therapeutic relationship.
Key Takeaways
- Sleep disturbance is extremely common, affecting 30 to 35% of adults, and has profound effects on health, cognition, and quality of life.
- Classify sleep complaints by type (insomnia, hypersomnia, parasomnia) and duration (acute, short-term, chronic) to guide diagnosis and management.
- The history is paramount: use systematic approaches like the “SLEEPS” mnemonic and validated questionnaires (Epworth Sleepiness Scale, STOP-BANG) to ensure comprehensive assessment.
- Red flags requiring urgent evaluation include severe sleepiness with driving risk, suicidal ideation with insomnia, witnessed apneas with cardiovascular disease, and dream enactment behavior with injury.
- Physical examination focuses on upper airway assessment for obstructive sleep apnea (Mallampati score, neck circumference, craniofacial anatomy) but is often normal in insomnia, circadian disorders, and restless legs syndrome.
- Not all patients need sleep studies: clinical diagnosis is appropriate for chronic insomnia, restless legs syndrome, and circadian rhythm disorders. Reserve polysomnography for suspected sleep apnea, narcolepsy, and parasomnias.
- Cognitive behavioral therapy for insomnia (CBT-I) is first-line treatment for chronic insomnia and is more effective than medications long-term.
- Obstructive sleep apnea is underdiagnosed and can present atypically (insomnia, nocturia, resistant hypertension); maintain high index of suspicion.
- In restless legs syndrome, target ferritin greater than 75 micrograms per liter and avoid dopamine agonists as first-line therapy due to augmentation risk.
- REM sleep behavior disorder is a strong predictor of future synucleinopathy; patients deserve counseling and neurological follow-up.
- Always consider medication and substance contributions to sleep disturbance; addressing these is often more effective than adding sleep medications.
- Comorbidity is common—most patients have multiple factors contributing to their sleep disturbance, and comprehensive management requires addressing all of them.
Quick Reference Algorithm
Systematic Approach to Sleep Disturbance:
- Identify the primary complaint: Cannot sleep (insomnia)? Too sleepy (hypersomnia)? Abnormal behaviors (parasomnia)?
- Screen for red flags: Suicidal ideation, severe sleepiness with driving risk, witnessed apneas with cardiovascular disease, dream enactment with injury
- Take a systematic history: Use the “SLEEPS” mnemonic; obtain a sleep diary; administer validated questionnaires
- Perform targeted examination: Focus on upper airway, vital signs, neurological examination; remember that normal examination does not exclude pathology
- Order appropriate investigations: Baseline labs (ferritin, TSH, glucose) for all; sleep study if sleep apnea, narcolepsy, or parasomnia suspected; sleep diary and actigraphy for circadian disorders
- Consider comorbidity: Most patients have multiple contributing factors; address psychiatric, medical, and medication causes
- Initiate evidence-based treatment: CBT-I for insomnia; CPAP for obstructive sleep apnea; iron and alpha-2-delta ligands for restless legs syndrome; specialist referral for narcolepsy and complex cases
- Follow up and reassess: If treatment fails, reconsider diagnosis, adherence, and need for specialist referral